Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Integrative and Experimental Genomics, |
RCV000172967 | SCV000212145 | likely benign | Hypercholesterolemia, familial, 1 | criteria provided, single submitter | research | ||
Prevention |
RCV000246092 | SCV000303951 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Cardiovascular Research Group, |
RCV000172967 | SCV000322848 | uncertain significance | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | |
Robarts Research Institute, |
RCV000172967 | SCV000484824 | likely benign | Hypercholesterolemia, familial, 1 | 2019-08-22 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000246092 | SCV000538310 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC: 0.9% (61/6612) Finnish chromosomes |
Invitae | RCV001837739 | SCV000554815 | benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000246092 | SCV000593265 | uncertain significance | not specified | 2015-12-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000246092 | SCV000730567 | likely benign | not specified | 2017-09-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000759464 | SCV000888792 | benign | not provided | 2022-08-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000759464 | SCV001152136 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | APOB: BP4, BS2 |
Illumina Laboratory Services, |
RCV001142271 | SCV001302691 | uncertain significance | Hypercholesterolemia, autosomal dominant, type B | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001142272 | SCV001302692 | uncertain significance | Familial hypobetalipoproteinemia 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
ARUP Laboratories, |
RCV000759464 | SCV002048329 | benign | not provided | 2023-08-23 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004584360 | SCV002506422 | uncertain significance | See cases | 2021-12-08 | criteria provided, single submitter | clinical testing | ACMG categories: PM2,PP3 |
Ambry Genetics | RCV002399600 | SCV002668780 | likely benign | Cardiovascular phenotype | 2021-11-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genetics and Molecular Pathology, |
RCV001142271 | SCV002761900 | benign | Hypercholesterolemia, autosomal dominant, type B | 2021-09-22 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000759464 | SCV001743862 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000246092 | SCV001919040 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000759464 | SCV001972415 | likely benign | not provided | no assertion criteria provided | clinical testing |